Altria's Oral Nicotine Pouch Product Is Going Nationwide. Is the Stock a Buy in 2026?

Core Insights - Altria Group is transitioning from traditional cigarettes to safer alternatives, particularly nicotine pouches under the "on!" brand [1][4] - The company is expanding the availability of its "on! PLUS" nicotine pouches nationwide following FDA authorizations [2] - Despite a decline in cigarette sales, Altria's oral tobacco product revenue has shown minimal growth, indicating challenges in the transition to alternative products [7][8] Group 1: Company Strategy - Altria is pivoting away from smoking due to declining prevalence, with smoking rates in the U.S. dropping from 54% in 1954 to 11% in 2024 [4] - The company recognizes that quitting smoking has not necessarily led former smokers to its vaping products or nicotine pouches [5] Group 2: Market Performance - Altria experienced a nearly 10% decline in total cigarette sales last year, while oral tobacco product revenue grew less than 1% [7] - The smokeless tobacco products, such as Copenhagen and Skoal, still dominate the smaller segment of Altria's revenue from oral/smokeless products [7] Group 3: Growth Potential - The expansion of "on!" products from three states to all U.S. states is significant for increasing market access [9] - There is some momentum in unit shipment growth for Altria's nicotine pouches, aligning with the overall growth of the nicotine pouch category in the U.S. [9]